financetom
Business
financetom
/
Business
/
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Dec 16, 2024 5:33 AM

08:05 AM EST, 12/16/2024 (MT Newswires) -- Soligenix ( SNGX ) said Monday it has begun patient enrollment for its phase 3 study of its experimental therapy, HyBryte, to treat cutaneous T-cell lymphoma or CTCL.

The company said the study builds on previous phase 3 results and additional supportive research.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
State Street CFO Eric Aboaf to Depart in February 2025 for Non-Banking Role
State Street CFO Eric Aboaf to Depart in February 2025 for Non-Banking Role
Oct 17, 2024
07:20 AM EDT, 10/15/2024 (MT Newswires) -- State Street (STT) said Tuesday Chief Financial Officer Eric Aboaf has decided to leave the company in February 2025 to pursue a new opportunity outside the banking industry. State Street said it started an internal and external search for Aboaf's successor, and Aboaf will stay through February to ensure a smooth transition. Price:...
Goldman Sachs profit jumps 45% on investment banking strength
Goldman Sachs profit jumps 45% on investment banking strength
Oct 17, 2024
(Reuters) - Goldman Sachs' profit jumped 45% in the third quarter as the investment bank benefited from a rebound in dealmaking. It joined JPMorgan Chase, which also gained from an investment banking revival, as corporate clients became more confident in the economic outlook, spurring debt and equity offerings. Our performance demonstrates the strength of our world-class franchise in an improving...
Ryder System Approves New Buyback Program of Up to 2 Million Shares
Ryder System Approves New Buyback Program of Up to 2 Million Shares
Oct 17, 2024
07:24 AM EDT, 10/15/2024 (MT Newswires) -- Ryder System (R) said Tuesday that its board has approved a new discretionary share repurchase program that will allow management to buy back up to 2 million shares through Oct. 9, 2026. The company said it currently has an anti-dilutive share repurchase program in place for up to 2 million shares that will...
Boeing lines up $35 bln in funds through stock and bond sale, loan
Boeing lines up $35 bln in funds through stock and bond sale, loan
Oct 17, 2024
Oct 15 (Reuters) - Boeing ( BA ) filed papers with the U.S. markets regulator on Tuesday for raising up to $25 billion through a stock and debt offering and entered into a $10 billion credit agreement amid a crippling strike and upcoming debt maturities. The planemaker is looking to strengthen its finances that have been strained due to a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved